Jordan Asher, MD
Chief Clinical Officer & Chief Innovation Officer
MissionPoint Health Partners
523 Mainstream Drive
In his role with MissionPoint, Asher focuses on creating innovative models of care delivery and providing thought leadership on the future of healthcare at a national level, including authoring the blog The Positive Contrarian. Previously, he was the physician network executive for Saint Thomas Health where he led physician alignment strategies. Asher also served as medical director for a large multispeciality private practice. A member of the American College of Physician Executives and the American Society of Hypertension, he completed his medical training at Vanderbilt and earned a master's degree in Medial Management from the University of Texas, Dallas.
A new governor and many new legislators make 2019 a learning year as the state's top healthcare organizations seek to address a number of old issues and tweak some new solutions unveiled last year.
The American Heart Association and American College of Cardiology released updated cholesterol clinical guidelines in November 2018, taking a more nuanced approach to care over a patient's lifetime.
In an increasingly connected medical ecosystem where patient safety, health status improvement, and provider reimbursement are impacted at every point along the continuum, the need to efficiently, securely share data appears to have reached a tipping point.
A number of guideline changes and updates warrant more education around statin use and blood pressure monitoring, but local cardiologists say the higher standards are a game changer.
Dr. Ashish Shah is the driving force behind the growth and innovation at one of the nation's busiest heart transplant programs.
A TriStar Centennial, a team approach is key to hospital's successful ECMO program.
Sen. Lamar Alexander asks stakeholders and future leaders to weigh in on ways to improve health outcomes, lower costs.
Controlling pharmaceutical prices remains a hot topic, judging from the 6,415 comments received in response to the CMS proposed rule: "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."
Every company should have a succession plan. LHC plays a key role in planning for the next generation of leaders for an entire industry.